Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  HIV Infection

  Free Subscription


22.04.2024

1 AIDS
1 Ann Intern Med
1 Blood
2 Clin Infect Dis
1 J Acquir Immune Defic Syndr
2 J Am Acad Dermatol
2 J Infect Dis
1 J Med Virol
1 Lancet Infect Dis
1 PLoS Comput Biol
14 PLoS One
2 Vaccine


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. KADIYALA GN, Telwatte S, Wedrychowski A, Janssens J, et al
    Differential susceptibility of cells infected with defective and intact HIV proviruses to killing by obatoclax and other small molecules.
    AIDS. 2024 Apr 16. doi: 10.1097/QAD.0000000000003908.
    PubMed         Abstract available


    Ann Intern Med

  2. ALHAMMADI A, Alshawaf R, Chavda S, Ramondino S, et al
    Infectious Diseases: What You May Have Missed in 2023.
    Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0679.
    PubMed         Abstract available


    Blood

  3. PISZCZATOWSKI RT, Buelow H, Steidl U
    Heparan Sulfates and Heparan Sulfate Proteoglycans in Hematopoiesis.
    Blood. 2024 Mar 22:blood.2023022736. doi: 10.1182/blood.2023022736.
    PubMed         Abstract available


    Clin Infect Dis

  4. COYLE RP, Morrow M, Mann SC, Mainella V, et al
    Tenofovir-Diphosphate and Emtricitabine-Triphosphate Adherence Benchmarks in Dried Blood Spots for Persons with HIV Receiving Tenofovir Alafenamide and Emtricitabine-based Antiretroviral Therapy (QUANTI-TAF).
    Clin Infect Dis. 2024 Apr 18:ciae212. doi: 10.1093.
    PubMed         Abstract available

  5. BACHELARD A, Le Hingrat Q, Ferre VM, Le M, et al
    Salvage Therapy Including Foscarnet and Ibalizumab for Multidrug-Resistant Human Immunodeficiency Virus Type 2 Infection.
    Clin Infect Dis. 2024;78:1005-1010.
    PubMed         Abstract available


    J Acquir Immune Defic Syndr

  6. MUTETWA T, Liu Y, Silvera R, Evans M, et al
    Host Nuclear Genome Copy Number Variations Identify High-Risk Anal Precancers in People Living with HIV.
    J Acquir Immune Defic Syndr. 2024 Apr 15. doi: 10.1097/QAI.0000000000003409.
    PubMed         Abstract available


    J Am Acad Dermatol

  7. LEIBOWITZ R, Fischer A, Collins LF, Feldman RJ, et al
    HIV-related exclusion criteria in atopic dermatitis and prurigo nodularis clinical trials.
    J Am Acad Dermatol. 2024 Apr 12:S0190-9622(24)00633.
    PubMed        

  8. KIM RW, McKenzie NC, Leslie KS
    Retrospective review of Mpox: morphology and presentation in skin of color and sexual minorities.
    J Am Acad Dermatol. 2024 Apr 10:S0190-9622(24)00625.
    PubMed        


    J Infect Dis

  9. MURENZI G, Kim HY, Mivumbi JP, Gasana J, et al
    Incidence, Clearance and Persistence of Penile High-Risk Human Papillomavirus among Rwandan Men who have Sex with Men.
    J Infect Dis. 2024 Apr 16:jiae190. doi: 10.1093.
    PubMed         Abstract available

  10. BEGRE L, Boyd A, Plissonnier ML, Testoni B, et al
    Circulating HBV RNA and hepatitis B core-related antigen trajectories in persons with HIV/HBV coinfection and HBsAg loss on tenofovir therapy.
    J Infect Dis. 2024 Apr 16:jiae189. doi: 10.1093.
    PubMed         Abstract available


    J Med Virol

  11. MATUSALI G, Vergori A, Cimini E, Mariotti D, et al
    Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID-19 booster dose in persons with HIV.
    J Med Virol. 2024;96:e29598.
    PubMed         Abstract available


    Lancet Infect Dis


  12. Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet Infect Dis. 2024 Apr 16:S1473-3099(24)00158.
    PubMed         Abstract available


    PLoS Comput Biol

  13. ZITZMANN C, Ke R, Ribeiro RM, Perelson AS, et al
    How robust are estimates of key parameters in standard viral dynamic models?
    PLoS Comput Biol. 2024;20:e1011437.
    PubMed         Abstract available


    PLoS One

  14. AMONE A, Gabagaya G, Wavamunno P, Rukundo G, et al
    Enhanced peer-group strategies to support the prevention of mother-to-child HIV transmission leads to increased retention in care in Uganda: A randomized controlled trial.
    PLoS One. 2024;19:e0297652.
    PubMed         Abstract available

  15. DI GENNARO F, Segala FV, Guido G, Poliseno M, et al
    Knowledge, attitudes, and practices about HIV and other sexually transmitted infections among High School students in Southern Italy: A cross-sectional survey.
    PLoS One. 2024;19:e0301297.
    PubMed         Abstract available

  16. OZSAHIN DU, Khan NA, Aqeel A, Ahmad H, et al
    Mathematical modeling and dynamics of immunological exhaustion caused by measles transmissibility interaction with HIV host.
    PLoS One. 2024;19:e0297476.
    PubMed         Abstract available

  17. JACOB N, Rice B, Heekes A, Johnson LF, et al
    Can routine antenatal data be used to assess HIV antiretroviral therapy coverage among pregnant women? Evaluating the validity of different data sources in the Western Cape, South Africa.
    PLoS One. 2024;19:e0291844.
    PubMed         Abstract available

  18. KHUMALO PG, Carey M, Mackenzie L, Sanson-Fisher R, et al
    Cervical cancer screening knowledge and associated factors among Eswatini women: A cross-sectional study.
    PLoS One. 2024;19:e0300763.
    PubMed         Abstract available

  19. ASTAWESEGN FH, Mannan H, Stulz V, Conroy E, et al
    Understanding the uptake and determinants of prevention of mother-to-child transmission of HIV services in East Africa: Mixed methods systematic review and meta-analysis.
    PLoS One. 2024;19:e0300606.
    PubMed         Abstract available

  20. EZECHI OC, Akinsolu FT, Gbajabiamila TA, Idigbe IE, et al
    Sexual dysfunction among Nigerian women living with HIV infection.
    PLoS One. 2024;19:e0292294.
    PubMed         Abstract available

  21. BADEJO O, Wouters E, Van Belle S, Buve A, et al
    Latent class analysis of barriers to HIV testing services and associations with sexual behaviour and HIV status among adolescents and young adults in Nigeria.
    PLoS One. 2024;19:e0300220.
    PubMed         Abstract available

  22. DE SCHACHT C, Amorim G, Calvo L, Ntasis E, et al
    Time spent at health facility is a key driver of patient satisfaction, but did not influence retention to HIV care: A serial cross-sectional study in Mozambique.
    PLoS One. 2024;19:e0299282.
    PubMed         Abstract available

  23. DANG X, Hanson BA, Orban ZS, Jimenez M, et al
    Characterization of the brain virome in human immunodeficiency virus infection and substance use disorder.
    PLoS One. 2024;19:e0299891.
    PubMed         Abstract available

  24. TAKEM EN, Coox C, Shang J, Ndongmo C, et al
    The association between HIV pretreatment drug resistance and virological outcomes in children and adults in sub-Saharan Africa: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0300456.
    PubMed         Abstract available

  25. MUSIIME V, Rujumba J, Kakooza L, Namisanvu H, et al
    HIV prevalence among children admitted with severe acute malnutrition and associated factors with mother-to-child HIV transmission at Mulago Hospital, Uganda: A mixed methods study.
    PLoS One. 2024;19:e0301887.
    PubMed         Abstract available

  26. OCHONYE B, Emmanuel G, Abang R, Sanni OF, et al
    Prevalence and factors associated with psychological distress among key populations in Nigeria.
    PLoS One. 2024;19:e0300901.
    PubMed         Abstract available

  27. HIRSCH-MOVERMAN Y, Hsu A, Abrams EJ, Killam WP, et al
    Guidelines for tuberculosis screening and preventive treatment among pregnant and breastfeeding women living with HIV in PEPFAR-supported countries.
    PLoS One. 2024;19:e0296993.
    PubMed         Abstract available


    Vaccine

  28. TRINITE B, Durr E, Pons-Grifols A, O'Donnell G, et al
    VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice.
    Vaccine. 2024 Apr 18:S0264-410X(24)00473-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  29. SUKIK L, Chemaitelly H, Ayoub HH, Coyle P, et al
    Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient.
    Vaccine. 2024 Apr 13:S0264-410X(24)00440-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.